Insider Transactions in Q1 2025 at Mind Medicine (Mind Med) Inc. (MNMD)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2025
|
Carrie Liao Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,347
-1.59%
|
$14,082
$6.74 P/Share
|
|
Mar 25
2025
|
Mark Sullivan Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,576
-2.03%
|
$39,456
$6.74 P/Share
|
|
Mar 25
2025
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,836
-1.51%
|
$41,016
$6.74 P/Share
|
|
Mar 25
2025
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
21,208
-2.42%
|
$127,248
$6.74 P/Share
|
|
Mar 12
2025
|
Carrie Liao Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.01%
|
-
|
|
Mar 12
2025
|
Mark Sullivan Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+31.7%
|
-
|
|
Mar 12
2025
|
Dan Karlin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
115,000
+20.25%
|
-
|
|
Mar 12
2025
|
Robert Barrow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350,000
+28.51%
|
-
|